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CORRELATION OF LOWER RESPIRATORY TRACT INFLAMMATION
WITH CHANGES IX LUNG FUNCTION AND CHEST
ROENTGENOGRAMS IN PATIENTS WITH UNTREATED TROPICAL
PULMONARY EOSINOPHILIA
V K Vijayan, K.Sankaran, P Venkatesan, K V Kuppurao
ABSTRACT
Forty-one patients with untreated tropical pulmonary eosinophilia (TPE) were studied to determine whether there was any
relationship between lower respiratory tract inflammation and either changes in lung function or abnormalities in chest
roentgenograms. Total number of inflammatory cells in bronchoalveolar lavage (BAL)fluid, consisting of alveolar macrophages,
lymphocytes, eosinophils and neutrophils had significant negative correlations with transfer factor (TLCO) (r=-0519, p<0.001),
transfer coefficient (KCO) (r=-0.3!2, p<0.05) and total lung capacity (TLC) (r=-0.352, p<0.05). The absolute count of eosinophils
in BAL fluid had a signifiant negative correlation with TLC0 (r=-0.430, p<0.01)and KC  (r=-0.300, p=0.05), but not with
forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1) r TLC. However, the absolute count of alveolar
macrophages had a significant negative correlation with FVC (r=-0.343, p<0.05), FEVI (r=- 341, p<0.05) and TLC (r=-0.305,
p<0.05), but not with TLC0 or KCO. The total number of lymphocytes had a negative correlation with TLC (r=-0.315, p<0.05).
There was no correlation between the types of cells recovered in BAL/fluid and changes in chest radiographs as assessed by the
IL0 classification for occupational lung diseases. These data suggest that there may be a dissociation of pulmonary
pathophysiological changesproduced by different inflammatory cells in the lower respiratory tract. Macrophages and lymphocytes
may produce more harm to the lung, as evidenced by significant negative correlations of these cells with lung volumes.
Keywords : Tropical pulmonary eosinophilia, lower respiratory tract inflammation, lung function, bronchoalveolar lavage, chest
roentgenograms.
INTRODUCTION
Studies of bronchoalveolar lavage (BAL) in patients with acute
untreated tropical pulmonary eosinophilia (TPE) have shown
that there is an intense eosinophilic alveolitis(1) and this is
associated mainly with a reduction in single-breath transfer
factor (TLCO) in most patients(2). A proportion of patients have
obstructive, restrictive and combined ventilatory defects in
addition(3,4). Although there were studies correlating the lower
respiratory tract inflammation. as assessed by BAL, to changes
in lung function in patients with sarcoidosis and idiopathic
pulmonary fibrosis(5,6), such a study has not been reported in
patients with tropical pulmonary eosinophilia. As eosinophils
have been shown to produce toxic mediators which are injurious
to lung parenchyma(7), leading to chronic progressive tissue
damage with interstitial fibrosis in bronchopulmonary
aspergillosis (a condition similar to tropical pulmonary
eosinophilia)(8,9), the impairment in lung function, reflecting
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underlying lung injury, may be a direct result of the
inflammatory reaction in the lower respiratory tract of patients
with acute TPE. A study was therefore undertaken to define
precisely the respective roles of distinct cell components in
alveolar sites (macrophages, lymphocytes, eosinophils and
neutrophils) implicated in the pathophysiological changes
observed in TPE.
SUBJECTS AND METHODS
Forty-one consecutive patients (38 males and 3 females, age
15-52 years) with symptoms of one week to six months’
duration, and fulfilling the diagnostic criteria of respiratory-
symptoms such as cough, dyspnoea and nocturnal wheezing,
pulmonary infiltrates and peripheral blood eosinophilia > 2000
cells/mm3 were included in the study. Each individual was
evaluated by a derailed history. physical examination, a full
plate PA chest radiograph, total and differential leucocyte counts
and absolute eosinophil counts in peripheral blood. Stool
examinations were done to exclude any infestation with
intestinal helminths. Informed consent was obtained from all
study subjects. A chest physician (VKV), experienced in reading
chest radiographs for nearly 15 years, read all chest radiographs
randomly at the end of the study, using the modified IL0 U/C
classificalion(1O).
Lung Function Tests:
Lung function tests were carried out using transfer test Model
C (PK Morgan Ltd. Chatham, UK). Forced vital capacity (FVC)
and forced expiratory volume in 1 second (FEV1) were
determined from the best 2 of 3 acceptable forced vital capacity
manoeuvres varying by not more than ±5%(11). The largest FVC
and FEV1 values at BTPS were recorded, even if the two values
did not come from the same curve. Total lung capacity (TLC)
was measured by closed circuit helium dilution method(12) by
obtaining, in each patient, two functional residual capacity
(FRC) measurement which did not vary by more than ±10%.
The mean value of these two measurements was used to
determine FRC at BTPS. The single-breath diffusing
measurements(12) were carried out in each individual, in
duplicate, with an interval of at least 4 minutes, adjusting the
inspired volume to 85-90% of previously determined FVC.
The values were accepted, if the difference between the two
measurements was less than 5% and the highest value was
used for analysis. The diffusion capacity per litre of alveolar
volume (KCO) was calculated from the ratio of TLCO to
effective alveolar volume (VA). Pulmonary function results were
expressed as percent of predicted values obtained from
regression equations established in our laboratory(4). The
coefficients of variation for FVC, TLC, TLCO and KCO in
our laboratory was less than 2.5%.
BAL was performed with a flexible fibreoptic brochoscope as
previously described and all bronchoscopies were done under
local anaesthesia. Briefly, five 20 ml aliquots of normal saline
at room temperature were instilled into each lobe and recovered
immediaiely using suction with 50-100 mm water negative
pressure, the bronchoscope being wedged in a sub-segmental
bronchus of the right middle lobe, lingula and left lower lobe.
The fluid was filtered through gauze to remove mucus and
was pooled An aliquot was used for filter preparations. The
total number of cells was estimated on a haemocytometer and
expressed as cells/dl. Filter preparations were made on pooled
lavage fluid (uncentrifuged cells) as reported by Saltini et al(14)
and were stained using haematoxylin-eosin stain. A minimum
of 400 cells were counted on each slide by two experienced
observers (VKV,KS) and recorded independently. Both
observers agreed to within 5% of all lavage analysis and the
mean value was used for analysis. BAL was also performed on
17 nomal non-smoking individuals as controls. None of these
subjects had respiratory symptoms or abnormal physical
findings and all had normal chest radiographs and normal
pulmonary functions.
All data are expressed as mean ± SEM. Results between
groups were compared using two tailed students’ ‘t’ test. For
correlations,we used Pearson’s product moment correlation.
RESULTS
The mean age of the study subjects was 23.9 ± 1.1 years
(range 15-52years). The mean total number of inflammatory
and immune effector cells (Table I) in the lower respiratory
tract in TPE  patients was 160.3 ± 17.1 cells x 106/dl (range 24-
575 cellsx 106/dl); this was significantly higher compared to
normal subjects (p<0.001). Except for two patients, all others
had total number of cells greater than 40x106/dl. The mean
eosinophil percentage (50.0 ± 4.5, range 1-99%) was also
significantly higher compared to normals (p<0.001) and only
two patientshad eosinophils of less than 10% in the lower
respiratory tract. The mean proportion of alveolar macrophages
fell significantly (p<0.001) to 43.9 ± 4.2% (range 1 to 91%).
One patient with symptoms for only one week had a normal
percentage of eosinophils (1%) in the lower respiratory tract;
other BAL findings and pulmonary functions were also within
normal limits. The absolute (total) numbers of different cell
types (totalnumber of cells x differential cell count (%)) are
shown in Table I. The mean total number of alveolar
macrophages (60.3 ± 6.4) and total number of eosinophils (91.6
± 16.3) were significantly higher compared to normal subjects
(p<0.001for each comparison).
The chest radiographs had a predominance of rounded
alveolar opacities in a dense profusion throughout both lung
fields. The ILO profusion opacities ranged from 1/1 to 3/3.
There was no relationship between radiographic changes and
BAL findings or functional changes. Pulmonary function results
expressed aspercent of predicted values are shown in Fig 1.
Among the 41 patients, who had TLCO measured, 36 (88%)
had results of less than 85% of the predicted. A reduction in
both TLC and FVC of less than 85% of predicted was seen in
18 (44%) patients. FEV1/F C% was less than 75% in 14 (34%)
patients. TLCO had a positive correlation with FVC (r=0.551.
p<0.001). FEV1(r=0.557, p<0.0001) and TLC (r=0.533, p<0.001).
Table I
BAL findings in patients with tropical pulmonary
eosinophilla and healthy control subjects (Mean ± SEM)
Tropical Pulmonary Healthy P
Eosinophilia controls value
(n:41) (n:17)
Total cells, x 106/d1
Macrophages, %
x 106/dl
Lymphocytes, %
x 106/dl
Eosinophils. %
x 106/dl                              
Neutrophils, %
x106/dl
160.3
±17.1
43.9
±4.2
60.3
±6.4
3.4
±0.6
4.0
±0.9
50.0
±4.5
91.6
±16.3
2.6
±1.4
4.3
±7 5
16.1
±1.7
83.5
±1.5
13.4
±1.4
14.9
±1.6
2.5
±0.4
0.9
±0.3
0.13
±0.04
0.7
±0.2
0.10
±0.03
<0.001
<0.001
<0.001
<0.001
NS
<0.001
<0.001
NS
NS
NS: Not Significant
Fig. 1
Pulmonary function in patients with tropical
pulmonary eosinophilia
(Mean - SEM)
The correlations of BAL cellular constitutents to various
pulmonary function measurements are given in Table II. We
found that total number of cells in BAL fluid had a negative
correlation with TLC (r=-0.352, p<0.05). TLCO (r=-0.519.
p<0.001) and KC0 (r=-0.312, p<0.05). Similarly, total number
of eosinophils in BAL fluid had a negative correlation with
TLCO (r=-0.430, p<0.01. Fig 2) and KC0 (r=-0.300, p=0.05).
However, the total number of alveolar macrophages in BAL
fluid had a significant negative correlation with FVC (r=-0.343.
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Table II
Correlations of BAL cells with Pulmonary function in TPE
Total cells Macrophages
x106/dl x106/dl
r P r P
Lymphocytes
x106/dl
r P
Eosinophils
x 106/dl
r P
FVC -0.287 NS -0.343 <0.05 -0.171 NS -0.159 NS 0.059 NS
(% Pred.)
FEV1
            (% Pred.)
TLC
(% Pred.)
-0.251 NS -0.341 <0.05 -0.110 NS -0.131 NS 0.061 NS
-0.352 <0.05 -0.305 <0.05 -0.315 <0.05 -0.236 NS 0.025 NS
TLCO -0.519 <O.OOl -0.287 NS -0.108 NS -0.430 <0.01 0.022 NS
(% Pred.)
KCO -0.312 4 . 0 5 -0.097 NS 0.129 NS -0.300 =0.05 0.010 NS
(% Pred.)
NS: Not Significant
Fig 2
Relationship of TLCO with BAL Eosinophils
l
p<0.05). FEV1 (r=-0.341, p<0.05) and TLC (r=-0.305. p<0.05).
TLC also had a significant negative correlation with total
number of lymphocytes (r=-0.315, p<0.05) and a total number
of lymphocytes had a positive correlation with total number of
macrophages (r=0.340, p<0.05).
DISCUSSION
A significant increase in the proportion and total number of
eosinophils along with a significant rise in total number of
inflammatory and immune effector cells in the lower respiratory
tract of patients with untreated tropical pulmonary eosinophilia
corroborates our earlier observation of eosinophilic alveolitis
in 8 acute tropical pulmonary eosinophilia patients(1). Al hough
there was a reciprocal significant reduction in proportion of
alveolar macrophages, the total number of alveolar macrophages
was significantly higher as a result of a significant rise in total
number of inflammatory cells. Thus. the inflammation in the
lower respiratory tract in patients with untreated TPE is due to
an abnormal accumulation of both alveolar macrophages and
eosinophils, resulting in macrophage-eosinophilic alveolitis.
Similar two cell interactions leading to alveolitis have been  
described in other interstitial lung diseases as well(15).
Activated macrophages and eosinophils are capable of
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producing spontaneously various toxic mediators resulting in
injury and fibrosis to lungparenchyma(7,16). The electron
microscopic demonsnationof severe degranulation with loss
of both the core and peripheral portion of granules 5 eosinophils
recovered from the lower respiratory tract of TPE patients(1),
suggests that these cells are possibly activated and may be
responsible for pathologicalch nges seen in these patients.
One of our study subjects, who had a one-week history of
symptoms, showed no increase in total number of inflammatory
cells or proportion of different cell types in lavage fluid. He
had normal pulmonary function including measurements of
diffusing capacity. This suggests that in the very early stages
of the illness there may not be any influx of eosinophils into
the lower respiratory tract.
The finding of a reduced single-breath diffusing capacity 
in 88% of patients suggests that the alveolitis resulting from
the abnormally accumulated inflammatory cells can cause injury
to lung parenchyma. The significant correlation of TLCO to
lung volumes such as TLC, FVC and FEV1 further suggests that
inflammatory changes in the lower respiratory tract are severe
enough to produce reductions in  lu g volumes as well. Similar
observation of a significant correlation of TLCO with FVC
has been reported in sarcoidosis(5). In this study, we could not
find any correlation between absolute number of inflammatory
cells recoveredby BAL fluid and chest roentgenogram findings
or lungfunction abnormalities. Similar findings have been
described in other interstitial lung diseases as well(17,18). There is
no correlation between BAL findings and chest radiographic
changes because radiographic abnormalities reflect both
inflammatory and fibrotic changes in the lung, while BAL
detects only pulmonary inflammation(17). He ce the lack of
correlation between BAL findings and chest radiographic
changes in our study subjects with less than 6 months of
symptoms suggest the possibility that early fibrosis, in addition
to pulmonary inflammation, has occurred in TPE.
The findings of a significant negative correlation of total
number of inflammatory cells and absolute eosinophil count in
lavage fluid in both TLCO and KCO suggest that the alveolitis,
causal by the abnormal accumulation of inflammatory cells
and eosinophils in particular, may be responsible for the
impairment of diffusing capacity. Similarly, a significant
correlation of BAL fluid eosinophilia with a reduced diffusing
capacity of the lung, but not with vital capacity or forced
expiratory volume has been reported in idiopathic pulmonary
fibrosis(29). However, Watters et al(6) reported that BAL fluid
eosinophils had a negative correlation with FVC in idiopathic
pulmonary fibrosis. while a negative correlation of BAL fluid
lymphocytes with diffusing capacity had been reported in
sarcoicosis25.
Interestingly, the total number of alveolar macrophages 
had a significant negative correlation with lung volumes such
 as TLC, FVC and FEV1, and the absolute lymphocyte count
had a significant negative correlation with TLC. Since the
recovery of macrophages and lymphocytes was related, as
evidenced by a positive correlation between these two types of
cells, the reaction in lung volumes in untreated TPE may be
due to cytotoxic products liberated by these cells(16). The
findings of a significant negative correlation of the eosinophil
count to TLCO and KCO, and also the absolute counts of
macrorphages and lymphocytes IO lung volumes indicate that
there maybe a dissociation of pathophysiological changes
produced by these cells in untreated TPE. The changes may be
due to a variety of toxic mediators produced by activated
inflammatory cells and the modes of action of these mediators
may vary at different sites. Further immunological studies with
serial lavage are required to answer these questions.
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